| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/03/2006 | WO2005097195A3 Methods of reducing aggregation of il-1ra |
| 08/03/2006 | WO2005095361A8 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| 08/03/2006 | WO2005092302A3 Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen |
| 08/03/2006 | WO2005092062A3 Compounds for neurodegenerative disorders |
| 08/03/2006 | WO2005084392A3 4-methylpyrazole formulations for inhibiting ethanol intolerance |
| 08/03/2006 | WO2005079849A3 Compounds for enhanced cancer therapy |
| 08/03/2006 | WO2005076958A3 Methods of determining the prognosis and treatment of subjects with pin 1 associated disorders |
| 08/03/2006 | WO2005062890A3 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel |
| 08/03/2006 | WO2005059098A3 Methods and compositions for treating and/or preventing neurodegenerative conditions |
| 08/03/2006 | WO2005046659A3 Migraine treatments including isovaleramide compounds and serotonin agonists |
| 08/03/2006 | WO2005039551A3 Solid pharmaceutical dosage form comprising an hiv protease inhibitor solid dispersion |
| 08/03/2006 | WO2005039480A3 AChE ANTISENSE DEOXYOLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 08/03/2006 | WO2005037225A3 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 08/03/2006 | WO2004112864A3 Medical devices and methods for regulating the tissue response to vascular closure devices |
| 08/03/2006 | WO2004093803A3 Photochemotherapeutic compounds for use in treatment of pin1-associated states |
| 08/03/2006 | WO2004086412A3 Radiation protection by gamma-tocotrienol |
| 08/03/2006 | WO2004082399A3 Fish and the production thereof |
| 08/03/2006 | WO2004075781A3 Bioactive stents and methods for use thereof |
| 08/03/2006 | WO2004007680A3 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |
| 08/03/2006 | WO2003072033A3 Common ligand mimics: thiazolidinediones and rhodanines |
| 08/03/2006 | WO2003014318A3 Methods for treating diabetes and other blood sugar disorders |
| 08/03/2006 | US20060173204 New 3-aryl propionic acid derivatives and analogs |
| 08/03/2006 | US20060173198 Synthesis of dimeric, trimeric, tetrameric, pentameric, and higher oligomeric epicatechin-derived procyanidins having 4beta,8-interflavan linkages and their use to inhibit cancer cell growth through cell cycle arrest |
| 08/03/2006 | US20060173193 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases |
| 08/03/2006 | US20060173190 Nematicidal thiazoline-containing fluorobutenes |
| 08/03/2006 | US20060173181 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| 08/03/2006 | US20060173178 Reducing 2-nitro-2'-carboxy-diphenylsulfide derivative in presence of hydrogen gas and reduction catalyst; subjecting 2-amino-2'-carboxy-diphenylsulfide derivative to dehydration-condensation to produce dibenzo[b,f][1,4]thiazepin-11-one compound |
| 08/03/2006 | US20060173081 Treating morning migraines with propranolol |
| 08/03/2006 | US20060173080 Methods of modulating TNF using bupropion |
| 08/03/2006 | US20060173079 Compositions and methods for improving the condition of patients suffering from copd and other diseases |
| 08/03/2006 | US20060173078 Method of treatment or prophylaxis of symptoms of herpes viral infection |
| 08/03/2006 | US20060173077 Surgical method |
| 08/03/2006 | US20060173076 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173074 Treatment of restless legs syndrome |
| 08/03/2006 | US20060173073 Microfine zinc-glycerol complexes |
| 08/03/2006 | US20060173072 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound |
| 08/03/2006 | US20060173071 Mast cell stabilizers used to inhibit laminitis |
| 08/03/2006 | US20060173070 Method of enhancing motor function |
| 08/03/2006 | US20060173069 Therapeutic agent for hyperpotassemia and bone disease |
| 08/03/2006 | US20060173068 Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 08/03/2006 | US20060173067 Small molecules for the treatment of atherosclerosis |
| 08/03/2006 | US20060173066 Remedy for diabetes |
| 08/03/2006 | US20060173065 Functionalized phenolic esters and amides and polymers therefrom |
| 08/03/2006 | US20060173064 (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders |
| 08/03/2006 | US20060173063 Exo-(t-butyl 2R(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylate, intermediates, and process to prepare and isolate them |
| 08/03/2006 | US20060173062 Use of selective cyclooxygenase-2 inhibitors for the treatment of endometriosis |
| 08/03/2006 | US20060173061 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 08/03/2006 | US20060173060 Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems |
| 08/03/2006 | US20060173059 Agent for preventing or treating portal hypertension |
| 08/03/2006 | US20060173058 Kcnq channel modulating compounds and their pharmaceutical use |
| 08/03/2006 | US20060173057 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173055 Pyrrole compounds useful as kinase inhibitors |
| 08/03/2006 | US20060173054 Treating Alzheimer's disease; e.g. 2',3',4',5,5',6,7,8,9,10-Decahydro-2-(5-(4-fluorophenyl)-1-methyl-pyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)-spiro(6,9-methanobenzocyclooctene-11,3'-(1,2,5)thiadiazole)-1',1'-dioxide |
| 08/03/2006 | US20060173053 Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| 08/03/2006 | US20060173052 Use of the non-opiate analgesic drug flupirtine of the treatment of overactive bladder and associated diseases including urge incontinence, urinary flow problems as a result of prostate hyperplasia and irritable bowl syndrome |
| 08/03/2006 | US20060173051 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 08/03/2006 | US20060173050 Inhibitors of c-Jun N-terminal kinases |
| 08/03/2006 | US20060173049 enzyme inhibitors such as 6-{2-(2-Chloro-phenyl)-5-[4-(pyrimidin-2-yloxy)-phenyl]pyrrol-1-ylmethyl}-pyridin-2-ylamine, used to treat beta-amyloid deposits and neurofibrillary tangles; Alzheimer's disease |
| 08/03/2006 | US20060173048 Imidazole derivatives |
| 08/03/2006 | US20060173047 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics |
| 08/03/2006 | US20060173046 Hydroxypyridine cgrp receptor antagonists |
| 08/03/2006 | US20060173045 Preventative or remedy for grinding |
| 08/03/2006 | US20060173044 Substituted propargylamines |
| 08/03/2006 | US20060173043 Use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
| 08/03/2006 | US20060173042 Process for the preparation of fexofenadine |
| 08/03/2006 | US20060173041 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 08/03/2006 | US20060173040 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173038 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
| 08/03/2006 | US20060173037 Aminophenyl derivatives as selective androgen receptor modulators |
| 08/03/2006 | US20060173036 4-{[3-(3-aminopropyl)-5-(diisobutylamino)-3H-imidazo[4,5-b]pyridin-2-yl]amino}-N-methylbenzamide hydrochloride; melanocortin receptors MC4 modulator; analgesic agent; neuropatic pain; antidepressant, anxiolytic agent; obesity |
| 08/03/2006 | US20060173035 3-Aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173033 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 08/03/2006 | US20060173032 Isolation and structure of cribrostatin 6 |
| 08/03/2006 | US20060173031 Therapeutic agent for schizophrenia |
| 08/03/2006 | US20060173030 Antitumoral analogs of lamellarins |
| 08/03/2006 | US20060173029 Oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone |
| 08/03/2006 | US20060173028 Therapeutic and/or preventive agent for chronic skin disease |
| 08/03/2006 | US20060173027 Spirocvclic piperidines as mch1 antagonists and uses thereof |
| 08/03/2006 | US20060173026 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents |
| 08/03/2006 | US20060173025 2-Substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole [2,3-d]pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof |
| 08/03/2006 | US20060173024 Compositions and methods for treating heart failure |
| 08/03/2006 | US20060173023 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| 08/03/2006 | US20060173022 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
| 08/03/2006 | US20060173021 pyrazinyl, pyrimidinyl and pyridazinyl derivatives such asN-[5-(2-Chloro-5-trifluoromethyl-phenyl)-pyrazin-2-yl]-2,6-difluoro-benzamide, used as immunosuppressants for the treatmet or prevent inflammatory and immune disorders |
| 08/03/2006 | US20060173020 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 08/03/2006 | US20060173019 Heteroaryl sulfonamides and CCR2 |
| 08/03/2006 | US20060173018 Quinazolines useful as modulators of ion channels |
| 08/03/2006 | US20060173017 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 08/03/2006 | US20060173016 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; treatment of cancer; additional anticancer drug or radiotherapy. |
| 08/03/2006 | US20060173015 Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060173013 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 08/03/2006 | US20060173012 4-(6-(p-substituted phenyl)-3-pyridazinyl)-1-isopropylpiperazines, e.g., 4-[6-(4-Isopropylpiperazin-1-yl)-pyridazin-3-yl]benzonitrile; treatment of diseases or disorders related to the histamine H3 receptor, e.g., obesity, eating disorders, osteoarthritis, type 2 diabetes, allergic rhinitis, & narcolepsy |
| 08/03/2006 | US20060173011 Treatment of inflammatory disorders with praziquantel |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173009 Agent inducing increase in bone mass |